Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Venous Thromboembolism | 18 | 2024 | 1670 | 3.190 |
Why?
|
Thrombophilia | 4 | 2023 | 305 | 2.360 |
Why?
|
Hemophilia A | 6 | 2022 | 351 | 2.330 |
Why?
|
Antithrombin III Deficiency | 3 | 2023 | 30 | 1.970 |
Why?
|
Antithrombin III | 5 | 2023 | 128 | 1.800 |
Why?
|
Anticoagulants | 17 | 2024 | 4599 | 1.770 |
Why?
|
Hemostasis | 4 | 2023 | 458 | 1.570 |
Why?
|
Heparin | 4 | 2021 | 1637 | 1.540 |
Why?
|
Hemostatics | 3 | 2022 | 229 | 1.500 |
Why?
|
Upper Extremity Deep Vein Thrombosis | 2 | 2021 | 26 | 1.480 |
Why?
|
Fibrinogens, Abnormal | 2 | 2020 | 10 | 1.480 |
Why?
|
Afibrinogenemia | 2 | 2020 | 17 | 1.480 |
Why?
|
Anemia, Sickle Cell | 5 | 2022 | 1018 | 1.400 |
Why?
|
Postthrombotic Syndrome | 3 | 2014 | 28 | 1.390 |
Why?
|
Venous Thrombosis | 8 | 2020 | 1238 | 1.300 |
Why?
|
Drug Monitoring | 4 | 2021 | 956 | 1.290 |
Why?
|
Blood Coagulation Disorders | 2 | 2023 | 337 | 1.270 |
Why?
|
Hemorrhage | 8 | 2021 | 3461 | 1.020 |
Why?
|
Hemophilia B | 2 | 2016 | 81 | 0.900 |
Why?
|
Thrombolytic Therapy | 4 | 2021 | 2161 | 0.890 |
Why?
|
Deamino Arginine Vasopressin | 1 | 2022 | 91 | 0.850 |
Why?
|
Thrombosis | 4 | 2023 | 2968 | 0.830 |
Why?
|
Blood Coagulation | 5 | 2022 | 1127 | 0.800 |
Why?
|
22q11 Deletion Syndrome | 1 | 2021 | 17 | 0.790 |
Why?
|
Partial Thromboplastin Time | 2 | 2019 | 206 | 0.740 |
Why?
|
Thoracic Outlet Syndrome | 1 | 2021 | 86 | 0.730 |
Why?
|
Catheterization, Swan-Ganz | 1 | 2019 | 86 | 0.690 |
Why?
|
Cytapheresis | 1 | 2018 | 8 | 0.680 |
Why?
|
Frameshift Mutation | 1 | 2020 | 399 | 0.650 |
Why?
|
Pulmonary Embolism | 4 | 2021 | 2375 | 0.640 |
Why?
|
Klinefelter Syndrome | 1 | 2018 | 49 | 0.630 |
Why?
|
Adolescent | 35 | 2022 | 85759 | 0.620 |
Why?
|
Vena Cava, Inferior | 2 | 2018 | 436 | 0.610 |
Why?
|
Factor Xa | 2 | 2019 | 162 | 0.610 |
Why?
|
Mesenteric Arteries | 1 | 2018 | 183 | 0.610 |
Why?
|
Exercise Therapy | 2 | 2022 | 906 | 0.610 |
Why?
|
Popliteal Artery | 1 | 2019 | 317 | 0.600 |
Why?
|
Nomograms | 1 | 2019 | 228 | 0.590 |
Why?
|
Fibrinogen | 1 | 2020 | 894 | 0.590 |
Why?
|
Child, Preschool | 23 | 2021 | 40992 | 0.580 |
Why?
|
von Willebrand Disease, Type 3 | 2 | 2013 | 5 | 0.570 |
Why?
|
Thrombocytopenia | 2 | 2016 | 1175 | 0.570 |
Why?
|
von Willebrand Disease, Type 2 | 1 | 2016 | 8 | 0.570 |
Why?
|
Valproic Acid | 1 | 2019 | 445 | 0.560 |
Why?
|
Child | 33 | 2024 | 77679 | 0.540 |
Why?
|
Arterial Occlusive Diseases | 1 | 2019 | 793 | 0.510 |
Why?
|
Antithrombin Proteins | 1 | 2014 | 9 | 0.500 |
Why?
|
Decision Support Systems, Clinical | 1 | 2024 | 1162 | 0.490 |
Why?
|
Angioplasty, Balloon | 1 | 2018 | 653 | 0.490 |
Why?
|
Lower Extremity | 2 | 2019 | 1158 | 0.490 |
Why?
|
Thromboembolism | 1 | 2021 | 985 | 0.480 |
Why?
|
Infant | 20 | 2021 | 35129 | 0.480 |
Why?
|
Fibrinolytic Agents | 2 | 2023 | 2158 | 0.470 |
Why?
|
Point Mutation | 1 | 2019 | 1624 | 0.460 |
Why?
|
Decompression, Surgical | 1 | 2018 | 594 | 0.460 |
Why?
|
Blood Coagulation Factors | 1 | 2016 | 355 | 0.460 |
Why?
|
Heterozygote | 1 | 2019 | 2805 | 0.420 |
Why?
|
Central Nervous System Neoplasms | 1 | 2020 | 895 | 0.420 |
Why?
|
von Willebrand Diseases | 1 | 2013 | 127 | 0.420 |
Why?
|
Sinus Thrombosis, Intracranial | 1 | 2012 | 103 | 0.400 |
Why?
|
Dermatofibrosarcoma | 1 | 2011 | 63 | 0.400 |
Why?
|
Factor VIII | 4 | 2022 | 348 | 0.390 |
Why?
|
Orthopedic Procedures | 1 | 2021 | 1288 | 0.390 |
Why?
|
Databases, Factual | 3 | 2023 | 7730 | 0.390 |
Why?
|
Histiocytic Sarcoma | 1 | 2011 | 44 | 0.380 |
Why?
|
Infant, Newborn | 11 | 2022 | 25618 | 0.370 |
Why?
|
Body Weight | 2 | 2021 | 4666 | 0.370 |
Why?
|
Sports | 2 | 2016 | 688 | 0.370 |
Why?
|
Ischemia | 1 | 2019 | 1914 | 0.370 |
Why?
|
Genes, p16 | 1 | 2011 | 157 | 0.370 |
Why?
|
Acute Chest Syndrome | 1 | 2010 | 31 | 0.360 |
Why?
|
Young Adult | 17 | 2022 | 56436 | 0.350 |
Why?
|
Anticonvulsants | 1 | 2019 | 1917 | 0.340 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2011 | 222 | 0.340 |
Why?
|
Humans | 61 | 2024 | 744220 | 0.330 |
Why?
|
Wilms Tumor | 1 | 2011 | 373 | 0.330 |
Why?
|
Ribs | 2 | 2021 | 252 | 0.330 |
Why?
|
Prednisone | 2 | 2011 | 1575 | 0.330 |
Why?
|
Male | 38 | 2022 | 350027 | 0.320 |
Why?
|
Brain Ischemia | 1 | 2022 | 3265 | 0.320 |
Why?
|
Aneurysm, False | 1 | 2011 | 276 | 0.320 |
Why?
|
Executive Function | 1 | 2017 | 1362 | 0.310 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2011 | 694 | 0.310 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2011 | 546 | 0.300 |
Why?
|
Stroke | 2 | 2022 | 9981 | 0.300 |
Why?
|
von Willebrand Factor | 3 | 2016 | 669 | 0.290 |
Why?
|
Lymphoma, Follicular | 1 | 2011 | 435 | 0.290 |
Why?
|
Genetic Association Studies | 1 | 2016 | 2702 | 0.280 |
Why?
|
Pelvis | 1 | 2011 | 729 | 0.280 |
Why?
|
Blood Coagulation Tests | 2 | 2017 | 263 | 0.270 |
Why?
|
Female | 32 | 2023 | 380197 | 0.260 |
Why?
|
Mutation | 5 | 2023 | 29784 | 0.260 |
Why?
|
Quality of Life | 2 | 2016 | 12805 | 0.230 |
Why?
|
Drug Dosage Calculations | 2 | 2021 | 114 | 0.230 |
Why?
|
Adult | 19 | 2023 | 214035 | 0.230 |
Why?
|
Body Mass Index | 1 | 2021 | 12718 | 0.220 |
Why?
|
Neoplasms, Second Primary | 1 | 2011 | 1061 | 0.220 |
Why?
|
Cognition Disorders | 1 | 2017 | 4041 | 0.210 |
Why?
|
Retrospective Studies | 14 | 2022 | 77426 | 0.210 |
Why?
|
Risk Factors | 14 | 2024 | 72280 | 0.200 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2017 | 5442 | 0.200 |
Why?
|
Embolization, Therapeutic | 1 | 2011 | 1392 | 0.190 |
Why?
|
Hospitalization | 1 | 2020 | 10262 | 0.190 |
Why?
|
Phenotype | 4 | 2023 | 16365 | 0.190 |
Why?
|
Glucocorticoids | 1 | 2010 | 2108 | 0.190 |
Why?
|
Follow-Up Studies | 5 | 2021 | 39045 | 0.190 |
Why?
|
Severity of Illness Index | 3 | 2021 | 15538 | 0.190 |
Why?
|
Antithrombins | 1 | 2023 | 304 | 0.180 |
Why?
|
Acute Generalized Exanthematous Pustulosis | 1 | 2009 | 13 | 0.180 |
Why?
|
Amoxicillin-Potassium Clavulanate Combination | 1 | 2009 | 30 | 0.180 |
Why?
|
Exercise | 1 | 2016 | 5615 | 0.170 |
Why?
|
Half-Life | 2 | 2019 | 659 | 0.160 |
Why?
|
Obesity | 1 | 2021 | 12742 | 0.160 |
Why?
|
Cohort Studies | 5 | 2021 | 40559 | 0.160 |
Why?
|
Cellulitis | 1 | 2009 | 206 | 0.150 |
Why?
|
Phlebography | 1 | 2018 | 333 | 0.150 |
Why?
|
Genotype | 3 | 2018 | 12956 | 0.140 |
Why?
|
Ultrasonography, Doppler | 1 | 2018 | 458 | 0.140 |
Why?
|
Drug Eruptions | 1 | 2009 | 297 | 0.140 |
Why?
|
Hemarthrosis | 1 | 2016 | 38 | 0.140 |
Why?
|
Edetic Acid | 1 | 2016 | 276 | 0.140 |
Why?
|
Skin Neoplasms | 2 | 2014 | 5670 | 0.140 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2021 | 611 | 0.140 |
Why?
|
Patient Readmission | 1 | 2010 | 3114 | 0.130 |
Why?
|
Diagnosis, Differential | 3 | 2018 | 12961 | 0.130 |
Why?
|
Prognosis | 3 | 2021 | 29050 | 0.130 |
Why?
|
Kidney Neoplasms | 1 | 2011 | 4245 | 0.130 |
Why?
|
Nail Diseases | 1 | 2014 | 51 | 0.120 |
Why?
|
Thrombelastography | 1 | 2016 | 163 | 0.120 |
Why?
|
Pilot Projects | 2 | 2018 | 8321 | 0.120 |
Why?
|
Platelet Count | 1 | 2016 | 781 | 0.110 |
Why?
|
Urogenital Neoplasms | 1 | 2014 | 135 | 0.110 |
Why?
|
Cross-Sectional Studies | 3 | 2021 | 25043 | 0.110 |
Why?
|
Genes, X-Linked | 1 | 2013 | 128 | 0.110 |
Why?
|
Eye Neoplasms | 1 | 2014 | 313 | 0.110 |
Why?
|
Immunoassay | 1 | 2016 | 752 | 0.110 |
Why?
|
Inpatients | 1 | 2024 | 2518 | 0.100 |
Why?
|
Survival Rate | 2 | 2020 | 12781 | 0.100 |
Why?
|
Treatment Outcome | 7 | 2021 | 63119 | 0.100 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2012 | 11493 | 0.100 |
Why?
|
Mucous Membrane | 1 | 2014 | 668 | 0.100 |
Why?
|
Prevalence | 2 | 2018 | 15226 | 0.090 |
Why?
|
Leukemia, Biphenotypic, Acute | 1 | 2010 | 35 | 0.090 |
Why?
|
Leukemia, T-Cell | 1 | 2010 | 104 | 0.090 |
Why?
|
Vascular Surgical Procedures | 1 | 2019 | 1475 | 0.090 |
Why?
|
Genes, Recessive | 1 | 2013 | 643 | 0.090 |
Why?
|
Genes, Dominant | 1 | 2013 | 880 | 0.090 |
Why?
|
Structure-Activity Relationship | 1 | 2016 | 3133 | 0.090 |
Why?
|
Binding Sites | 1 | 2019 | 6116 | 0.090 |
Why?
|
Family | 1 | 2021 | 3148 | 0.090 |
Why?
|
Enzyme Activation | 1 | 2016 | 3701 | 0.090 |
Why?
|
Furans | 1 | 2011 | 194 | 0.090 |
Why?
|
Prospective Studies | 3 | 2023 | 53280 | 0.080 |
Why?
|
Diagnostic Errors | 1 | 2016 | 1255 | 0.080 |
Why?
|
Vincristine | 1 | 2011 | 1036 | 0.080 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2010 | 537 | 0.080 |
Why?
|
Hospitals, Pediatric | 1 | 2017 | 1766 | 0.080 |
Why?
|
Remission Induction | 2 | 2011 | 2389 | 0.080 |
Why?
|
Jugular Veins | 1 | 2009 | 204 | 0.080 |
Why?
|
Protein Conformation | 1 | 2016 | 4012 | 0.080 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2011 | 2649 | 0.080 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2011 | 704 | 0.080 |
Why?
|
Exons | 1 | 2013 | 2439 | 0.070 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2014 | 989 | 0.070 |
Why?
|
Incidence | 3 | 2022 | 20945 | 0.070 |
Why?
|
Thiophenes | 1 | 2011 | 589 | 0.070 |
Why?
|
Pedigree | 1 | 2014 | 4648 | 0.070 |
Why?
|
Logistic Models | 2 | 2018 | 13409 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 3 | 2019 | 35423 | 0.070 |
Why?
|
Recurrence | 1 | 2018 | 8343 | 0.070 |
Why?
|
Calcium | 1 | 2019 | 5757 | 0.070 |
Why?
|
Case-Control Studies | 2 | 2021 | 21752 | 0.070 |
Why?
|
Models, Molecular | 1 | 2016 | 5458 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2022 | 9960 | 0.070 |
Why?
|
DNA Mutational Analysis | 1 | 2014 | 4188 | 0.060 |
Why?
|
Cyclophosphamide | 1 | 2011 | 2236 | 0.060 |
Why?
|
Cell Separation | 1 | 2011 | 1751 | 0.060 |
Why?
|
Transplantation Conditioning | 1 | 2012 | 1598 | 0.060 |
Why?
|
Doxorubicin | 1 | 2011 | 2220 | 0.060 |
Why?
|
Hodgkin Disease | 1 | 2012 | 1415 | 0.060 |
Why?
|
Mutation, Missense | 1 | 2013 | 2563 | 0.060 |
Why?
|
Physicians | 1 | 2022 | 4564 | 0.060 |
Why?
|
Age Factors | 2 | 2021 | 18367 | 0.060 |
Why?
|
Base Sequence | 1 | 2014 | 12801 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 2 | 2014 | 17449 | 0.050 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2010 | 1581 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2009 | 7179 | 0.050 |
Why?
|
Homeodomain Proteins | 1 | 2010 | 2422 | 0.050 |
Why?
|
Survival Analysis | 1 | 2014 | 10250 | 0.050 |
Why?
|
Embolectomy | 1 | 2021 | 120 | 0.050 |
Why?
|
Head and Neck Neoplasms | 1 | 2014 | 2732 | 0.050 |
Why?
|
Tumor Suppressor Proteins | 1 | 2010 | 2848 | 0.050 |
Why?
|
Flow Cytometry | 1 | 2011 | 5974 | 0.050 |
Why?
|
Postoperative Complications | 1 | 2022 | 15294 | 0.040 |
Why?
|
Repressor Proteins | 1 | 2010 | 3023 | 0.040 |
Why?
|
Prothrombin Time | 1 | 2019 | 119 | 0.040 |
Why?
|
Cognition | 1 | 2017 | 6765 | 0.040 |
Why?
|
Graft vs Host Disease | 1 | 2012 | 2957 | 0.040 |
Why?
|
Radiology, Interventional | 1 | 2022 | 460 | 0.040 |
Why?
|
North America | 1 | 2022 | 1250 | 0.040 |
Why?
|
Depression | 1 | 2017 | 7767 | 0.040 |
Why?
|
Melanoma | 1 | 2014 | 5475 | 0.030 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2010 | 3523 | 0.030 |
Why?
|
Neutropenia | 1 | 2019 | 895 | 0.030 |
Why?
|
Consensus | 1 | 2022 | 2958 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2012 | 13668 | 0.030 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2018 | 780 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2019 | 4929 | 0.020 |
Why?
|
Bacteremia | 1 | 2018 | 962 | 0.020 |
Why?
|
Acute Disease | 1 | 2021 | 7148 | 0.020 |
Why?
|
United States | 1 | 2018 | 69867 | 0.020 |
Why?
|
Anemia | 1 | 2019 | 1504 | 0.020 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2010 | 351 | 0.020 |
Why?
|
Combined Modality Therapy | 2 | 2012 | 8628 | 0.020 |
Why?
|
Gestational Age | 1 | 2018 | 3493 | 0.020 |
Why?
|
Hematologic Diseases | 1 | 2012 | 498 | 0.020 |
Why?
|
Middle Aged | 1 | 2021 | 213367 | 0.020 |
Why?
|
Catheters, Indwelling | 1 | 2009 | 425 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2010 | 1526 | 0.020 |
Why?
|
Translocation, Genetic | 1 | 2010 | 1420 | 0.020 |
Why?
|
Length of Stay | 1 | 2018 | 6308 | 0.020 |
Why?
|
Sex Factors | 1 | 2018 | 10396 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4752 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2010 | 2763 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2012 | 6893 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2012 | 6535 | 0.010 |
Why?
|
Risk Assessment | 1 | 2022 | 23337 | 0.010 |
Why?
|
Ultrasonography | 1 | 2009 | 5982 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2010 | 13036 | 0.010 |
Why?
|